PATENT CLAIM ANALYSIS

Application Number: 16020463
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["530", "300000"]

Abstract:
The isolation and identification of glycosaminoglycans capable of binding to proteins having a heparin-binding domain is disclosed, as well as the use of the glycosaminoglycans isolated in the growth and/or development of tissue.

Claim (Index 23):
The method of  claim 21  wherein the heparan sulfate complexes are contacted with a lyase.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 94.0
- Lexical Diversity: 1.25
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13062364', '15262895', '13603569', '15336407', '14891564']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.818378428343375
- 35 USC 102 Novelty (BERT): 0.578151087021492
- Combined Prediction Score: 0.7943556942111868
- Mean Citation Score: 602.032898
- Max Citation Score: 685.2466400000002
- Similarity Product: 378.6030637426902

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test